ENZON PHARMACEUTICALS, INC. 10-K Cybersecurity GRC - 2026-03-02

Page last updated on March 2, 2026

ENZON PHARMACEUTICALS, INC. reported their cybersecurity risk management and governance process in a yearly 10-K filed on 2026-03-02 16:56:20 EST.

Filings

10-K filed on 2026-03-02

ENZON PHARMACEUTICALS, INC. filed a 10-K at 2026-03-02 16:56:20 EST
Accession Number: 0001104659-26-022313

Note: filing items unformatted. Drop us a note with the above URL to help us prioritize formatting it!

Item 1C. Cybersecurity.

Item 1C. Cybersecurity As we have positioned ourselves as a public company acquisition vehicle, and have limited operations, we do not have any significant operations that face cybersecurity threats. Although we do depend on the digital technologies of third parties , and any deliberate attacks on, or security breaches in, systems or infrastructure that we utilize, including those of third parties, could lead to corruption or misappropriation of our assets, information and sensitive or confidential data, we do not consider that we face significant cybersecurity risk and have not adopted any cybersecurity risk management program or formal processes for assessing cybersecurity risk . Our board of directors is generally responsible for the oversight of risks from cybersecurity threats, if there is any, as such threats may pertain to the protection of our assets, and our Finance and Audit Committee is responsible for the oversight of risks from cybersecurity threats, as such threats may pertain to financial risks and exposures. In fiscal year 2025, we did not identify any cybersecurity threats that have materially affected or are reasonably likely to materially affect our business strategy, results of operations, or financial condition.

Company Information